Safer Prescribing Webinar Series
Upcoming Sessions
Benzodiazepines: Prescribing, Tapering, and Polysubstance Use
July 23rd, 2026
12:00pm-1:30pm ET
Date: July 23rd
Time: 12:00pm-1:30pm ET
Moderator: Michael Smith, PharmD, BCPS
Speakers: Amy Vandenberg, PharmD, Alek Adkins, MD
Target Audience: Physicians and Medical Students, although the session is open to all
At the conclusion of this activity, participants will be able to:
- Describe appropriate indications for the use of benzodiazepines
- Evaluate the risks of co-prescribing opioids and benzodiazepines (CDC Clinical Practice Guideline Recommendation 11)
- Outline a benzodiazepine tapering plan
Nursing and Opioids: Providing Pain Care and Preventing Overdose
August 5th, 2026
12:30pm-2:00pm ET
Date: August 5th
Time: 12:30pm-2:00pm ET
Moderator: Michael Smith, PharmD, BCPS
Speakers: Deborah Russell, APRN-CNP, Elizabeth Haberkorn, DNP, FNP-BC
Target Audience: Nurses, physicians and Medical Students, although the session is open to all
At the conclusion of this activity, participants will be able to:
- Explain ways to care for patients experiencing pain
- Describe ways to support patients during the tapering process
- Recognize opportunities to improve patient experience and understanding
Stimulants: Prescribing, Risks, and Management
August 20th, 2026
12:00pm-1:00pm ET
Date: August 20th
Time: 12:00pm-1:00pm ET
Moderator: Michael Smith, PharmD, BCPS
Speakers: Allison Forbes, MSN, PMHNP-BC
Target Audience: Nurses, physicians and Medical Students, although the session is open to all
At the conclusion of this activity, participants will be able to:
- Describe appropriate indications for the use of stimulants
- Evaluate the risks of co-prescribing opioids and stimulants
- Create a stimulant management plan through shared decision-making
Past Session Recordings
Session 1: Reviewing the CDC Clinical Practice Guidelines
Session 2: Equity in Pain Management and Access to SUD Treatment
Session 3: Harm Reduction
Session 4: MOUD and Acute Pain
Management
Session 5: Effective Conversations about Pain Management
Session 6: MOUD and Pregnancy
Continuing Education Credits
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Injury Prevention Center. MyMichigan Health is accredited by the Michigan State Medical Society to provide continuing medical education for physicians. MyMichigan Health designates this activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation:
MyMichigan Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MyMichigan Health designates this live activity for a maximum of 1.5 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Event Disclosures:
Speakers:
Alek Adkins, MD, Michael Smith, PharmD, and Amy Vandenberg, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Alek Adkins, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Potentially gabapentin for alcohol use disorder Buprenorphine & benzodiazepine co-administration
Michael Smith, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Acetaminophen and non-steroidal anti-inflammatory drug off-label use for dental-related pain.
Amy Vandenberg, PharmD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: alternative treatments for anxiety (eg, prazosin, propranolol)
Elizabeth Haberkorn, DNP, Deborah Russell, APRN, and Michael Smith, PharmD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Planners and other Administrative Support:
Lisa Orrison, Taylor Hautala, Nichole Burnside, and Jill Solomon have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.”
